Capital Development Marketing Westlake Village 
socalTECH
DECEMBER 15, 2020
Westlake Village-based Eta Compute , a developer of technology for energy efficient artificial intelligence processing, has raised $12.5M The company's lead product is the TENSAI AI software platform, which it says is aimed at use in AI applications for the smart home and consumer Internet-of-Things markets.
socalTECH
JULY 5, 2017
Westlake Village-based Sienna Biopharmaceuticals , a startup biopharmaceuticals firm developing products for the medical dermatology and aesthetics market, has filed for an IPO. in an offering on the NASDAQ Global Market. Morgan, Cowen, and BMO Capital Markets. Morgan, Cowen, and BMO Capital Markets.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
JANUARY 27, 2020
So far this year four privately held companies have made the transition to trading on the public markets. By month’s end, five more are anticipated to join the class of 2020 initial public offerings—and four of those are in life sciences, according to IPO research firm Renaissance Capital.
socalTECH
JULY 27, 2017
Westlake Village-based Sienna Biopharmaceuticals had its IPO this morning on the NASDAQ, and was up over 33 percent in morning trading on its first day trading as SNNA, trading at around $19.98. The aesthetic medicine developer, led by President and CEO Dr. The aesthetic medicine developer, led by President and CEO Dr. Frederick C.
socalTECH
JANUARY 31, 2019
Westlake Village-based Avinew , a new startup looking at developing auto insurance for the autonomous vehicle market, has raised $5M in a seed funding round, according to the company. The funding was led by Crosscut Ventures, and also included American Family Ventures, Draper Frontier, and RPM Ventures.
socalTECH
APRIL 22, 2016
Westlake Village-based electronics maker Interlink Electronics said Thursday afternoon, that its shares have been approved for listing on the NASDAQ Capital Market. Interlink Electronics develops force sensing and other electronics. READ MORE>>.
socalTECH
JULY 13, 2016
Westlake Village-based Sienna Biopharmaceuticals has had a second close on its Series A funding, bringing the total raised in the round to $46M, the company said on Tuesday. The funding was led by ARCH Venture Partners and Partner Fund Management, and also included Two River, Altitude Life Science Ventures, Venvest Capital, and angels.
Expert insights. Personalized for you.
113 
Let's personalize your content